Chapter 05 - Pharmaco

Showing all 29 results

Pharmaco 01 – Endpoints in Experimental Animal Models
$5.00
Pharmaco 02 – Colonic Transit Study
$5.00
Pharmaco 03 – GI and Colonic Transit Test
$5.00
Pharmaco 04 – Wireless Motility Capsule Recordings in Health
$5.00
Pharmaco 05 – Colonic Transit Study (Metcalf Technique)
$5.00
Pharmaco 06 – Barostat Bag Placement in Descending Colon
$5.00
Pharmaco 07 – Methods to Measure Rectal Compliance
$5.00
Pharmaco 08 – Preganalin Increases Thresholds to Rectal Distension in IBS
$5.00
Pharmaco 09 – Rectal Hypersensitivity in IBS is Associated with Greater Symptom
$5.00
Pharmaco 10 – Rectal Barostat Sensory Test in IBS
$5.00
Pharmaco 11 – Onset and Rate of Gastric Emptying Varies with the Composition
$5.00
Pharmaco 12 – SPECT Method to Measure Gastric Volumes
$5.00
Pharmaco 13 – Maximum Tolerable Volume and Symptoms
$5.00
Pharmaco 14 – Applying Novel Nutrient Drink to Clinical Trial of Functional Dyspepsia
$5.00
Pharmaco 15 – High Resolution Recordings of Gastric Accommodation in Humans
$5.00
Pharmaco 16 – Potential Receptor Targets for FGID Treatment
$5.00
Pharmaco 17 – Potential Local Targets for Drug Action in the Gut
$5.00
Pharmaco 18 – Cytochrome P450 (CYP)
$5.00
Pharmaco 19 – Propose Pathophysiology of IBS
$5.00
Pharmaco 20 – Drug Discovery from Natural Medicines-Reverse PK and PD
$5.00
Pharmaco 21 – Site of Action of Different Classes on Medications
$5.00
Pharmaco 22 – Targets Directed at Pathophysiology of IBS
$5.00
Pharmaco 23 – Options for Testing Intestinal Permeability
$5.00
Pharmaco 24 – Biomarkers of Individualizing Therapy
$5.00
Pharmaco 25 – Etiological Mechanisms in IBS and Potential Biomarkers
$5.00
Pharmaco 26 – Proposed Biomarkers for IBS and Reported Sensitivity and Specificity
$5.00
Pharmaco 27 – Proof of Concept on the Role of Biomarkers in Individualizing Therapy
$5.00
Pharmaco 28 – Colesevelam Binds Bile Acids in Colon with Compensatory Increase
$5.00
Pharmaco 29 – In Patients with IBS-D and Increased Fecal Bile Acids
$5.00

Pharmaco 01 – Endpoints in Experimental Animal Models

Pharmaco 02 – Colonic Transit Study

Pharmaco 03 – GI and Colonic Transit Test

Pharmaco 04 – Wireless Motility Capsule Recordings in Health

Pharmaco 05 – Colonic Transit Study (Metcalf Technique)

Pharmaco 06 – Barostat Bag Placement in Descending Colon

Pharmaco 07 – Methods to Measure Rectal Compliance

Pharmaco 08 – Preganalin Increases Thresholds to Rectal Distension in IBS

Pharmaco 09 – Rectal Hypersensitivity in IBS is Associated with Greater Symptom

Pharmaco 10 – Rectal Barostat Sensory Test in IBS

Pharmaco 11 – Onset and Rate of Gastric Emptying Varies with the Composition

Pharmaco 12 – SPECT Method to Measure Gastric Volumes

Pharmaco 13 – Maximum Tolerable Volume and Symptoms

Pharmaco 14 – Applying Novel Nutrient Drink to Clinical Trial of Functional Dyspepsia

Pharmaco 15 – High Resolution Recordings of Gastric Accommodation in Humans

Pharmaco 16 – Potential Receptor Targets for FGID Treatment

Pharmaco 17 – Potential Local Targets for Drug Action in the Gut

Pharmaco 18 – Cytochrome P450 (CYP)

Pharmaco 19 – Propose Pathophysiology of IBS

Pharmaco 20 – Drug Discovery from Natural Medicines-Reverse PK and PD

Pharmaco 21 – Site of Action of Different Classes on Medications

Pharmaco 22 – Targets Directed at Pathophysiology of IBS

Pharmaco 23 – Options for Testing Intestinal Permeability

Pharmaco 24 – Biomarkers of Individualizing Therapy

Pharmaco 25 – Etiological Mechanisms in IBS and Potential Biomarkers

Pharmaco 26 – Proposed Biomarkers for IBS and Reported Sensitivity and Specificity

Pharmaco 27 – Proof of Concept on the Role of Biomarkers in Individualizing Therapy

Pharmaco 28 – Colesevelam Binds Bile Acids in Colon with Compensatory Increase

Pharmaco 29 – In Patients with IBS-D and Increased Fecal Bile Acids